New
New Features to Expect in 2018
It seems like a long time ago now (the holiday season has a way of stretching time in strange ways), but we sent you our newsletter just before the New Year with a sneak peek of our activities for this year.
To recap, we are switching to a monthly email newsletter and weekly Facebook posts unless you all write in to say No, Thanks or if the vitiligo world has very little of substance to report. You will receive regular news on vitiligo research, therapies, products, self-help, Q&A, with a touch of a gossip-celebrity-lifestyle-stuff.
Occasionally well have longer submissions on a specific topic, but that will be an exception to the rule and because the topic merits additional coverage. New products will hopefully be a regular section. We will be listing Vitiligo News contributors at the end of each edition.
Stay tuned for Vitiligo News!
FAQOther Questions
- What's better: laser or phototherapy?
Laser therapy is actually a type of phototherapy. Both rely on light to trigger changes in the skin, but they work differently. Phototherapy usually means a narrow-band UV (NB-U...
- Are there any famous people with vitiligo?
Many celebrities have dealt with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career. Here are a few courageous famous peo...
- How to get insurance coverage for vitiligo treatments?
Getting insurance coverage for vitiligo treatments can be challenging, but there are several steps you can take to improve your chances For a more in-depth look, check out our u...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.